OP0245 ANTI-S100A4 MONOCLONAL ANTIBODY TREATMENT AMELIORATES SKIN FIBROSIS IN INFLAMMATORY AND NON-INFLAMMATORY PRE-CLINICAL MODELS OF SYSTEMIC SCLEROSIS

Michal Tomčík^a, Thuong Trinh‐Minh^b, Cuong Tran Manh^b, Hana Štorkánová^a, Lenka Štorkánová^a, Ladislav Šenolt^a, Jörg Klingelhöfer^c, R. I. Hussain^c, J. Hallén^c, Jörg H. W. Distler^b

1. ^aInstitute of Rheumatology and First Faculty of Medicine, Charles University, Department of Rheumatology, Prague, Czech Republic
2. ^bDepartment of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Department of Internal Medicine III, Erlangen, Germany
3. ^cArxx Therapeutics, Arxx Therapeutics, Oslo, Norway